首页 > 最新文献

北京大学学报(医学版)最新文献

英文 中文
[Effect of aquaporin 5 on TLR4/MyD88/NF-κB signaling pathway in Sjögren syndrome rats]. [水通道蛋白5对Sjögren综合征大鼠TLR4/MyD88/NF-κB信号通路的影响]。
Q3 Medicine Pub Date : 2025-10-18
Lixiu Zhu, Renli Chen, Sujuan Zhou, Ye Lin, Yirong Tang, Zhen Ye

Objective: To investigate the effect of aquaporin 5 (AQP5) on Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor κB (NF-κB) signaling pathway in Sjögren syndrome (SS) rats.

Methods: The SS gene expression data sets GSE406611 and GSE84844 were extracted from the Gene Expression Omnibus (GEO), and the AQP5 mRNA expression was analyzed by R software. The rat SS model was constructed. The successfully modeled rats were divided into SS group, SS+NC group, and SS+pc group, 10 rats in each group; and 10 rats were set as Normal group. The rats in the SS+NC group were injected with 10 μg of rno-pcDNA3.1-AQP5-NC at the submandibular gland, subcutaneously every day for 28 days. The rats in the SS+pc group were injected with 10 μg of rno-pcDNA3.1-AQP5 at the submandibular gland, subcutaneously every day for 28 days. The enzyme-linked immunosorbent assay (ELISA) kit was used to detect the content of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the serum. High-throughput sequencing was used to identify the target genes. Quantitative real-time PCR (qPCR) and Western blot were used to detect the mRNA and protein expressions of AQP5, TLR4, MyD88, and NF-κB in the rat submandibular gland tissue.

Results: In the SS dataset GSE406611 and GSE84844, the mRNA expression of AQP5 in SS was significantly reduced. Compared with the Normal group, the content of TNF-α and IL-1β in the serum, the mRNA and protein expressions of TLR4, MyD88, and NF-κB in the SS group were significantly increased, the mRNA and protein expressions of AQP5 were significantly decreased. After overexpression of AQP5, the content of TNF-α and IL-1β in the serum, the mRNA and protein expressions of TLR4, MyD88, and NF-κB in the SS+pc group were significantly decreased, the mRNA and protein expressions of AQP5 were significantly increased. The differences were statistically significant (all P < 0.05).

Conclusion: The expression of AQP5 is involved in the progression of SS. Increasing the expression of AQP5 can significantly inhibit inflammatory stress and reduce the pathological damage of submandibular gland tissue. This may be related to the inhibition of TLR4/MyD88/NF-κB conduction.

目的:探讨水通道蛋白5 (AQP5)对Sjögren综合征(SS)大鼠toll样受体4 (TLR4)/髓样分化因子88 (MyD88)/核因子κB (NF-κB)信号通路的影响。方法:从gene expression Omnibus (GEO)中提取SS基因表达数据集GSE406611和GSE84844,用R软件分析AQP5 mRNA的表达。建立大鼠SS模型。将成功造模的大鼠分为SS组、SS+NC组和SS+pc组,每组10只;10只大鼠为正常组。SS+NC组大鼠每天在颌下腺皮下注射rno-pcDNA3.1-AQP5-NC 10 μg,连续28 d。SS+pc组大鼠每天在颌下腺皮下注射rno-pcDNA3.1-AQP5 10 μg,连续28 d。采用酶联免疫吸附试验(ELISA)试剂盒检测血清中肿瘤坏死因子-α (TNF-α)和白细胞介素-1β (IL-1β)的含量。采用高通量测序技术鉴定目的基因。采用实时荧光定量PCR (qPCR)和Western blot检测大鼠颌下腺组织中AQP5、TLR4、MyD88、NF-κB mRNA和蛋白的表达。结果:在SS数据集GSE406611和GSE84844中,AQP5在SS中的mRNA表达量显著降低。与正常组比较,SS组大鼠血清中TNF-α、IL-1β含量显著升高,TLR4、MyD88、NF-κB mRNA和蛋白表达显著升高,AQP5 mRNA和蛋白表达显著降低。过表达AQP5后,SS+pc组大鼠血清中TNF-α、IL-1β含量及TLR4、MyD88、NF-κB mRNA和蛋白表达量显著降低,AQP5 mRNA和蛋白表达量显著升高。差异均有统计学意义(P < 0.05)。结论:AQP5的表达参与了SS的进展,增加AQP5的表达可显著抑制炎症应激,减轻颌下腺组织的病理损伤。这可能与抑制TLR4/MyD88/NF-κB传导有关。
{"title":"[Effect of aquaporin 5 on TLR4/MyD88/NF-κB signaling pathway in Sjögren syndrome rats].","authors":"Lixiu Zhu, Renli Chen, Sujuan Zhou, Ye Lin, Yirong Tang, Zhen Ye","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effect of aquaporin 5 (AQP5) on Toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor κB (NF-κB) signaling pathway in Sjögren syndrome (SS) rats.</p><p><strong>Methods: </strong>The SS gene expression data sets GSE406611 and GSE84844 were extracted from the Gene Expression Omnibus (GEO), and the AQP5 mRNA expression was analyzed by R software. The rat SS model was constructed. The successfully modeled rats were divided into SS group, SS+NC group, and SS+pc group, 10 rats in each group; and 10 rats were set as Normal group. The rats in the SS+NC group were injected with 10 μg of rno-pcDNA3.1-AQP5-NC at the submandibular gland, subcutaneously every day for 28 days. The rats in the SS+pc group were injected with 10 μg of rno-pcDNA3.1-AQP5 at the submandibular gland, subcutaneously every day for 28 days. The enzyme-linked immunosorbent assay (ELISA) kit was used to detect the content of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in the serum. High-throughput sequencing was used to identify the target genes. Quantitative real-time PCR (qPCR) and Western blot were used to detect the mRNA and protein expressions of AQP5, TLR4, MyD88, and NF-κB in the rat submandibular gland tissue.</p><p><strong>Results: </strong>In the SS dataset GSE406611 and GSE84844, the mRNA expression of AQP5 in SS was significantly reduced. Compared with the Normal group, the content of TNF-α and IL-1β in the serum, the mRNA and protein expressions of TLR4, MyD88, and NF-κB in the SS group were significantly increased, the mRNA and protein expressions of AQP5 were significantly decreased. After overexpression of AQP5, the content of TNF-α and IL-1β in the serum, the mRNA and protein expressions of TLR4, MyD88, and NF-κB in the SS+pc group were significantly decreased, the mRNA and protein expressions of AQP5 were significantly increased. The differences were statistically significant (all <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The expression of AQP5 is involved in the progression of SS. Increasing the expression of AQP5 can significantly inhibit inflammatory stress and reduce the pathological damage of submandibular gland tissue. This may be related to the inhibition of TLR4/MyD88/NF-κB conduction.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"875-883"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparation of anterior maxilla and whole maxilla clockwise rotation to improve paranasal aesthetic defects of skeletal Class Ⅲ maxillofacial deformity]. [上颌前牙与全颌顺时针旋转改善骨类颌面畸形鼻旁审美缺陷的比较]。
Q3 Medicine Pub Date : 2025-10-18
Fengqi Song, Xinyu Xu, Xiaojing Liu, Zili Li

Objective: To compare the aesthetic effects of anterior maxilla clockwise rotation combined with segmental Le Fort Ⅰ osteotomy and whole maxilla clockwise rotation on improving paranasal concavity in patients with Class Ⅲ maxillofacial deformity.

Methods: A non-randomized controlled trial was designed, and 21 patients diagnosed with skeletal Class Ⅲ maxillofacial deformity were included. In the study, 11 patients in the test group were treated by segmental Le Fort Ⅰ osteotomy combined with anterior maxilla clockwise rotation, and 10 patients in the control group were treated by whole maxilla clockwise rotation. The CBCT and 3D photography of preoperative (T0), 2 weeks postoperative (T1), and 6 months postoperative (T2) were collected respectively, and the three-dimensional cephalometry was carried out. The differences of specific parameters between the two groups were compared by independent sample t-test, including saggital displacement of the cheek mass point (CK) and subalare point (SA), nasolabial angle, occlusal plane angle and labial inclination angle of the upper incisor.

Results: There were no significant differences of the parameters on T0 between the two groups. The average sagittal displacement of the upper incisors of the test group was (-0.71±1.67) mm and smaller than that of control group [(2.26±1.68) mm], t=-4.052, P < 0.05. The average angle of the occlusal plane clockwise rotation of the test group was 1.46°±2.38° and smaller than that of the control group (4.31°±1.83°), t=-3.047, P < 0.05. The angle of anterior maxilla clockwise rotation was 11.73°±2.81° during the surgery. The average saggital displacement of the paranasal soft tissue landmarks of the test group from T0 to T2 was larger than that of the control group [CK point, (4.96±1.18) mm vs. (2.01± 1.50) mm, P < 0.05;SA point, (5.19±1.17) mm vs. (2.69±1.45) mm, P < 0.05]. The labial inclination angle of the upper incisor of the test group was 112.15°±5.40° in T2 and significantly smaller than that of the control group (122.38°±8.83°), t=-3.237, P < 0.05. The nasolabial angle of the test group was 106.54°±12.82° in T2 and significantly larger than that of the control group (93.90°±12.46°), t=2.288, P < 0.05.

Conclusion: Compared with whole maxilla clockwise rotation, anterior maxilla clockwise rotation combined with segmental Le Fort Ⅰ osteotomy can increase the saggital displacement of the paranasal soft tissue, correct labial inclination of the upper incisors and the acute naso-labial angle and better improve the paranasal aesthetic defects in patients with Class Ⅲ maxillofacial deformity with less changing on the saggital orientation of the upper incisors and the occlusal plane angle.

目的:比较上颌前牙顺时针旋转联合节段性Le FortⅠ截骨术与整个上颌顺时针旋转治疗Ⅲ类颌面畸形患者鼻副凹陷的美学效果。方法:设计非随机对照试验,纳入21例骨骼类Ⅲ颌面畸形患者。实验组11例采用Le FortⅠ节段截骨联合前上颌顺时针旋转治疗,对照组10例采用全颌顺时针旋转治疗。分别收集术前(T0)、术后2周(T1)和术后6个月(T2)的CBCT和3D照片,并进行三维头颅测量。采用独立样本t检验比较两组患者颊肿块点(CK)和颌下点(SA)矢状位移、鼻唇角、咬合平面角、上切牙唇倾角等具体参数的差异。结果:两组患者T0指标无显著性差异。试验组上切牙矢状位平均位移为(-0.71±1.67)mm,小于对照组(2.26±1.68)mm, t=-4.052, P < 0.05。试验组牙合平面顺时针旋转的平均角度为1.46°±2.38°,小于对照组(4.31°±1.83°),t=-3.047, P < 0.05。术中上颌前牙顺时针旋转角度为11.73°±2.81°。试验组T0 ~ T2鼻旁软组织标志矢状位平均移位量大于对照组[CK点,(4.96±1.18)mm vs(2.01±1.50)mm, P < 0.05;SA点,(5.19±1.17)毫米和(2.69±1.45)毫米,P < 0.05)。试验组T2时上切牙唇倾角为112.15°±5.40°,显著小于对照组(122.38°±8.83°),t=-3.237, P < 0.05。试验组鼻唇角在T2时为106.54°±12.82°,显著大于对照组(93.90°±12.46°),t=2.288, P < 0.05。结论:与全颌顺时针旋转相比,上颌前牙顺时针旋转联合Le FortⅠ节段截骨术可以增加鼻旁软组织矢状位移,矫正上切牙唇倾和鼻唇角,更好地改善Ⅲ类颌面畸形患者的鼻旁美学缺陷,且上切牙矢状位和咬合平面角变化较小。
{"title":"[Comparation of anterior maxilla and whole maxilla clockwise rotation to improve paranasal aesthetic defects of skeletal Class Ⅲ maxillofacial deformity].","authors":"Fengqi Song, Xinyu Xu, Xiaojing Liu, Zili Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To compare the aesthetic effects of anterior maxilla clockwise rotation combined with segmental Le Fort Ⅰ osteotomy and whole maxilla clockwise rotation on improving paranasal concavity in patients with Class Ⅲ maxillofacial deformity.</p><p><strong>Methods: </strong>A non-randomized controlled trial was designed, and 21 patients diagnosed with skeletal Class Ⅲ maxillofacial deformity were included. In the study, 11 patients in the test group were treated by segmental Le Fort Ⅰ osteotomy combined with anterior maxilla clockwise rotation, and 10 patients in the control group were treated by whole maxilla clockwise rotation. The CBCT and 3D photography of preoperative (T0), 2 weeks postoperative (T1), and 6 months postoperative (T2) were collected respectively, and the three-dimensional cephalometry was carried out. The differences of specific parameters between the two groups were compared by independent sample <i>t</i>-test, including saggital displacement of the cheek mass point (CK) and subalare point (SA), nasolabial angle, occlusal plane angle and labial inclination angle of the upper incisor.</p><p><strong>Results: </strong>There were no significant differences of the parameters on T0 between the two groups. The average sagittal displacement of the upper incisors of the test group was (-0.71±1.67) mm and smaller than that of control group [(2.26±1.68) mm], <i>t</i>=-4.052, <i>P</i> < 0.05. The average angle of the occlusal plane clockwise rotation of the test group was 1.46°±2.38° and smaller than that of the control group (4.31°±1.83°), <i>t</i>=-3.047, <i>P</i> < 0.05. The angle of anterior maxilla clockwise rotation was 11.73°±2.81° during the surgery. The average saggital displacement of the paranasal soft tissue landmarks of the test group from T0 to T2 was larger than that of the control group [CK point, (4.96±1.18) mm <i>vs</i>. (2.01± 1.50) mm, <i>P</i> < 0.05;SA point, (5.19±1.17) mm <i>vs</i>. (2.69±1.45) mm, <i>P</i> < 0.05]. The labial inclination angle of the upper incisor of the test group was 112.15°±5.40° in T2 and significantly smaller than that of the control group (122.38°±8.83°), <i>t</i>=-3.237, <i>P</i> < 0.05. The nasolabial angle of the test group was 106.54°±12.82° in T2 and significantly larger than that of the control group (93.90°±12.46°), <i>t</i>=2.288, <i>P</i> < 0.05.</p><p><strong>Conclusion: </strong>Compared with whole maxilla clockwise rotation, anterior maxilla clockwise rotation combined with segmental Le Fort Ⅰ osteotomy can increase the saggital displacement of the paranasal soft tissue, correct labial inclination of the upper incisors and the acute naso-labial angle and better improve the paranasal aesthetic defects in patients with Class Ⅲ maxillofacial deformity with less changing on the saggital orientation of the upper incisors and the occlusal plane angle.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"980-988"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Artificial intelligence in stomatology: Innovations in clinical practice, research, education, and healthcare management]. 【口腔医学中的人工智能:临床实践、研究、教育和医疗管理方面的创新】。
Q3 Medicine Pub Date : 2025-10-18
Xuliang Deng, Mingming Xu, Chenlin DU

In recent years, China has continued to face a high prevalence of oral diseases, along with uneven access to high-quality dental care. Against this backdrop, artificial intelligence (AI), as a data-driven, algorithm-supported, and model-centered technology system, has rapidly expanded its role in transforming the landscape of stomatology. This review summarizes recent advances in the application of AI in stomatology across clinical care, biomedical and materials research, education, and hospital management. In clinical settings, AI has improved diagnostic accuracy, streamlined treatment planning, and enhanced surgical precision and efficiency. In research, machine learning has accelerated the identification of disease biomarkers, deepened insights into the oral microbiome, and supported the development of novel biomaterials. In education, AI has enabled the construction of knowledge graphs, facilitated personalized learning, and powered simulation-based training, driving innovation in teaching methodologies. Meanwhile, in hospital operations, intelligent agents based on large language models (LLMs) have been widely deployed for intelligent triage, structured pre-consultations, automated clinical documentation, and quality control, contributing to more standardized and efficient healthcare delivery. Building on these foundations, a multi-agent collaborative framework centered around an AI assistant for stomatology is gradually emerging, integrating task-specific agents for imaging, treatment planning, surgical navigation, follow-up prediction, patient communication, and administrative coordination. Through shared interfaces and unified knowledge systems, these agents support seamless human-AI collaboration across the full continuum of care. Despite these achievements, the broader deployment of AI still faces challenges including data privacy, model robustness, cross-institution generalization, and interpretability. Addressing these issues will require the development of federated learning frameworks, multi-center validation, causal reasoning approaches, and strong ethical governance. With these foundations in place, AI is poised to move from a supportive tool to a trusted partner in advancing accessible, efficient, and high-quality stomatology services in China.

近年来,中国继续面临口腔疾病的高患病率,以及获得高质量牙科保健的机会不均衡。在此背景下,人工智能作为一种数据驱动、算法支持、以模型为中心的技术体系,在改变口腔医学格局方面的作用迅速扩大。本文综述了人工智能在口腔临床护理、生物医学和材料研究、教育和医院管理等方面的应用进展。在临床环境中,人工智能提高了诊断准确性,简化了治疗计划,提高了手术精度和效率。在研究中,机器学习加速了疾病生物标志物的识别,加深了对口腔微生物组的了解,并支持了新型生物材料的开发。在教育领域,人工智能使知识图谱的构建成为可能,促进了个性化学习,并为基于模拟的培训提供了动力,推动了教学方法的创新。同时,在医院运营中,基于大型语言模型(llm)的智能代理已广泛用于智能分类、结构化预会诊、自动化临床文档和质量控制,有助于实现更标准化和更高效的医疗保健服务。在此基础上,以口腔医学人工智能助手为中心的多智能体协作框架正在逐渐出现,该框架整合了特定任务的智能体,用于成像、治疗计划、手术导航、随访预测、患者沟通和行政协调。通过共享界面和统一的知识系统,这些智能体支持在整个连续护理过程中实现人类与人工智能的无缝协作。尽管取得了这些成就,但人工智能的广泛部署仍然面临着包括数据隐私、模型鲁棒性、跨机构泛化和可解释性在内的挑战。解决这些问题需要开发联邦学习框架、多中心验证、因果推理方法和强有力的道德治理。有了这些基础,人工智能将从一个支持工具转变为一个值得信赖的合作伙伴,在中国推进可获得、高效和高质量的口腔医学服务。
{"title":"[Artificial intelligence in stomatology: Innovations in clinical practice, research, education, and healthcare management].","authors":"Xuliang Deng, Mingming Xu, Chenlin DU","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In recent years, China has continued to face a high prevalence of oral diseases, along with uneven access to high-quality dental care. Against this backdrop, artificial intelligence (AI), as a data-driven, algorithm-supported, and model-centered technology system, has rapidly expanded its role in transforming the landscape of stomatology. This review summarizes recent advances in the application of AI in stomatology across clinical care, biomedical and materials research, education, and hospital management. In clinical settings, AI has improved diagnostic accuracy, streamlined treatment planning, and enhanced surgical precision and efficiency. In research, machine learning has accelerated the identification of disease biomarkers, deepened insights into the oral microbiome, and supported the development of novel biomaterials. In education, AI has enabled the construction of knowledge graphs, facilitated personalized learning, and powered simulation-based training, driving innovation in teaching methodologies. Meanwhile, in hospital operations, intelligent agents based on large language models (LLMs) have been widely deployed for intelligent triage, structured pre-consultations, automated clinical documentation, and quality control, contributing to more standardized and efficient healthcare delivery. Building on these foundations, a multi-agent collaborative framework centered around an AI assistant for stomatology is gradually emerging, integrating task-specific agents for imaging, treatment planning, surgical navigation, follow-up prediction, patient communication, and administrative coordination. Through shared interfaces and unified knowledge systems, these agents support seamless human-AI collaboration across the full continuum of care. Despite these achievements, the broader deployment of AI still faces challenges including data privacy, model robustness, cross-institution generalization, and interpretability. Addressing these issues will require the development of federated learning frameworks, multi-center validation, causal reasoning approaches, and strong ethical governance. With these foundations in place, AI is poised to move from a supportive tool to a trusted partner in advancing accessible, efficient, and high-quality stomatology services in China.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"821-826"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549346/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Development and dissemination of precision medicine approaches in gastric cancer management]. [精准医学在胃癌治疗中的发展与推广]。
Q3 Medicine Pub Date : 2025-10-18
Zhemin Li, Jiafu Ji, Guoxin Li, Ziyu Li, Zhaode Bu, Xiangyu Gao, Di Dong, Lei Tang, Xiaofang Xing, Shuqin Jia, Ting Guo, Lianhai Zhang, Fei Shan, Xin Ji, Anqiang Wang

Gastric cancer is a high-incidence malignancy that poses a serious threat to public health in China, ranking among the top three cancers in both incidence and mortality. The majority of patients are diagnosed at an advanced stage, resulting in limited treatment options and poor prognosis. To address key challenges in gastric cancer diagnosis and treatment, a research team led by Professor Jiafu Ji at Peking University Cancer Hospital has focused on the project "Development and Dissemination of Precision Medicine Approaches in Gastric Cancer Management". Through a series of high-quality multicenter clinical studies, the team established a set of new international standards in perioperative treatment, individua-lized drug selection, intelligent noninvasive diagnostics, and novel immunotherapy strategies. These advances have significantly improved treatment efficacy and reduced surgical trauma, achieving key technological breakthroughs in diagnosis, therapy, and mechanistic understanding, and systematically enhancing outcomes for gastric cancer patients. The project ' s findings had a broad international impact, including hosting China ' s first International Gastric Cancer Congress. Through nationwide dissemination, they have promoted the development of precision diagnosis and treatment of gastric cancer as a discipline, and led the formulation of the National Health Commission's guidelines for gastric cancer diagnosis and treatment. In recognition of its achievements, the project was awarded the First Prize of the 2024 Chinese Medical Science and Technology Award.

胃癌是严重威胁中国公众健康的高发恶性肿瘤,其发病率和死亡率均位居癌症前三位。大多数患者在晚期被诊断出来,导致治疗选择有限和预后不良。为了解决胃癌诊断和治疗中的关键挑战,北京大学肿瘤医院季家富教授领导的研究团队专注于“胃癌管理中精准医学方法的发展和传播”项目。通过一系列高质量的多中心临床研究,团队在围手术期治疗、个体化药物选择、智能无创诊断、新型免疫治疗策略等方面建立了一套新的国际标准。这些进展显著提高了胃癌患者的治疗效果,减少了手术创伤,在诊断、治疗和机制认识方面取得了关键技术突破,系统地改善了胃癌患者的预后。该项目的研究结果具有广泛的国际影响,包括主办了中国首届国际胃癌大会。通过全国推广,推动胃癌精准诊疗学科发展,牵头制定国家卫健委胃癌诊疗指南。该项目获2024年中国医学科学技术奖一等奖,以表彰其成果。
{"title":"[Development and dissemination of precision medicine approaches in gastric cancer management].","authors":"Zhemin Li, Jiafu Ji, Guoxin Li, Ziyu Li, Zhaode Bu, Xiangyu Gao, Di Dong, Lei Tang, Xiaofang Xing, Shuqin Jia, Ting Guo, Lianhai Zhang, Fei Shan, Xin Ji, Anqiang Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gastric cancer is a high-incidence malignancy that poses a serious threat to public health in China, ranking among the top three cancers in both incidence and mortality. The majority of patients are diagnosed at an advanced stage, resulting in limited treatment options and poor prognosis. To address key challenges in gastric cancer diagnosis and treatment, a research team led by Professor Jiafu Ji at Peking University Cancer Hospital has focused on the project \"Development and Dissemination of Precision Medicine Approaches in Gastric Cancer Management\". Through a series of high-quality multicenter clinical studies, the team established a set of new international standards in perioperative treatment, individua-lized drug selection, intelligent noninvasive diagnostics, and novel immunotherapy strategies. These advances have significantly improved treatment efficacy and reduced surgical trauma, achieving key technological breakthroughs in diagnosis, therapy, and mechanistic understanding, and systematically enhancing outcomes for gastric cancer patients. The project ' s findings had a broad international impact, including hosting China ' s first International Gastric Cancer Congress. Through nationwide dissemination, they have promoted the development of precision diagnosis and treatment of gastric cancer as a discipline, and led the formulation of the National Health Commission's guidelines for gastric cancer diagnosis and treatment. In recognition of its achievements, the project was awarded the First Prize of the 2024 Chinese Medical Science and Technology Award.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"864-867"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Impact of palliative care on medication use and medical utilization in patients with advanced cancer]. [姑息治疗对晚期癌症患者用药和医疗利用的影响]。
Q3 Medicine Pub Date : 2025-10-18
Dingyi Chen, Haoxin DU, Yichen Zhang, Yanfei Wang, Wei Liu, Yuanyuan Jiao, Luwen Shi, Xiaodong Guan, Xinpu Lu

Objective: To evaluate the effect of palliative care on drug use, medical service utilization and medical expenditure of patients with advanced cancer.

Methods: A cohort of patients including pal-liative care and standard care was constructed using the medical records of the patients in Peking University Cancer Hospital from 2018 to 2020, and coarsened exact matching was used to match the two groups of patients. The average monthly opioid consumption, hospitalization rate, intensive care unit (ICU) rate and operation rate, and the average monthly total cost were selected to evaluate drug use, medical service utilization and medical expenditure. Chi-square test and Wilcoxon signed rank test were used to compare the differences between the two groups before and after exposure and the change in the palliative care group. The net impact of palliative care on the patients was calculated using the difference-in-differences analysis.

Results: In this study, 180 patients in the palliative care group and 3 101 patients in the stan-dard care group were finally included in the matching, and the matching effect of the two groups was good (L1 < 0.1). Before and after exposure, the average monthly opioid consumption in the palliative care group was significantly higher than that in the standard care group (Before exposure: 0.3 DDD/person-month vs. 0.1 DDD/person-month, P < 0.01; After exposure: 0.7 DDD/person-month vs. 0.1 DDD/person-month, P < 0.01; DDD refers to defined daily dose), palliative care significantly increased the average monthly opioid consumption in the patients (0.3 DDD/person-month, P < 0.01). The hospitalization rate (48.9% vs. 74.3%, P < 0.01) and operation rate (3.9% vs. 8.8%, P < 0.01) of the patients in palliative care group were significantly lower than those in standard care group, and the ICU rate became similar between the two groups (1.1% vs. 1.6%, P=0.634). Palliative care significantly reduced the patients ' hospitalization rate (-25.6%, P < 0.01), ICU rate (-4.9%, P < 0.01) and operation rate (-14.5%, P < 0.01). Before and after exposure, the average monthly total costs of pal-liative care group were slightly higher than those of standard care group (Before exposure: 20 092.3 yuan vs. 19 132.8 yuan, P=0.725; After exposure: 9 719.8 yuan vs. 8 818.8 yuan, P=0.165). Palliative care increased the average monthly total cost by 2 208.8 yuan, but it was not statistically significant (P=0.316).

Conclusion: Palliative care can increase the opioid consumption in advanced cancer patients, reduce the rates of hospitalization, ICU and surgery, but has no significant effect on medical expenditure.

目的:评价姑息治疗对晚期癌症患者用药、医疗服务利用及医疗支出的影响。方法:利用2018 - 2020年北京大学肿瘤医院患者病历,构建姑息治疗与标准治疗患者队列,采用粗化精确匹配方法对两组患者进行匹配。选取月平均阿片类药物使用量、住院率、重症监护病房(ICU)使用率和手术率以及月平均总费用来评价用药情况、医疗服务利用情况和医疗支出情况。采用卡方检验和Wilcoxon符号秩检验比较两组暴露前后的差异及姑息治疗组的变化。姑息治疗对患者的净影响采用差异中差异分析来计算。结果:本研究最终将姑息治疗组180例患者和标准治疗组3101例患者纳入匹配,两组匹配效果良好(L1 < 0.1)。暴露前后,姑息治疗组阿片类药物月平均用量显著高于标准治疗组(暴露前:0.3 DDD/人月vs. 0.1 DDD/人月,P < 0.01;暴露后:0.7 DDD/人月vs. 0.1 DDD/人月,P < 0.01; DDD为限定日剂量),姑息治疗显著提高了患者阿片类药物月平均用量(0.3 DDD/人月,P < 0.01)。姑息治疗组患者住院率(48.9% vs. 74.3%, P < 0.01)和手术率(3.9% vs. 8.8%, P < 0.01)均显著低于标准治疗组,两组患者ICU率基本持平(1.1% vs. 1.6%, P=0.634)。姑息治疗显著降低患者住院率(-25.6%,P < 0.01)、ICU率(-4.9%,P < 0.01)和手术率(-14.5%,P < 0.01)。暴露前后,姑息治疗组平均每月总费用略高于标准治疗组(暴露前:20 092.3元对19 132.8元,P=0.725;暴露后:9 719.8元对8 818.8元,P=0.165)。姑息治疗使患者平均每月总费用增加2 208.8元,但差异无统计学意义(P=0.316)。结论:姑息治疗可增加晚期癌症患者阿片类药物的消耗,降低住院率、ICU率和手术率,但对医疗支出无显著影响。
{"title":"[Impact of palliative care on medication use and medical utilization in patients with advanced cancer].","authors":"Dingyi Chen, Haoxin DU, Yichen Zhang, Yanfei Wang, Wei Liu, Yuanyuan Jiao, Luwen Shi, Xiaodong Guan, Xinpu Lu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effect of palliative care on drug use, medical service utilization and medical expenditure of patients with advanced cancer.</p><p><strong>Methods: </strong>A cohort of patients including pal-liative care and standard care was constructed using the medical records of the patients in Peking University Cancer Hospital from 2018 to 2020, and coarsened exact matching was used to match the two groups of patients. The average monthly opioid consumption, hospitalization rate, intensive care unit (ICU) rate and operation rate, and the average monthly total cost were selected to evaluate drug use, medical service utilization and medical expenditure. Chi-square test and Wilcoxon signed rank test were used to compare the differences between the two groups before and after exposure and the change in the palliative care group. The net impact of palliative care on the patients was calculated using the difference-in-differences analysis.</p><p><strong>Results: </strong>In this study, 180 patients in the palliative care group and 3 101 patients in the stan-dard care group were finally included in the matching, and the matching effect of the two groups was good (<i>L</i><sub>1</sub> < 0.1). Before and after exposure, the average monthly opioid consumption in the palliative care group was significantly higher than that in the standard care group (Before exposure: 0.3 DDD/person-month <i>vs</i>. 0.1 DDD/person-month, <i>P</i> < 0.01; After exposure: 0.7 DDD/person-month <i>vs</i>. 0.1 DDD/person-month, <i>P</i> < 0.01; DDD refers to defined daily dose), palliative care significantly increased the average monthly opioid consumption in the patients (0.3 DDD/person-month, <i>P</i> < 0.01). The hospitalization rate (48.9% <i>vs</i>. 74.3%, <i>P</i> < 0.01) and operation rate (3.9% <i>vs</i>. 8.8%, <i>P</i> < 0.01) of the patients in palliative care group were significantly lower than those in standard care group, and the ICU rate became similar between the two groups (1.1% <i>vs</i>. 1.6%, <i>P</i>=0.634). Palliative care significantly reduced the patients ' hospitalization rate (-25.6%, <i>P</i> < 0.01), ICU rate (-4.9%, <i>P</i> < 0.01) and operation rate (-14.5%, <i>P</i> < 0.01). Before and after exposure, the average monthly total costs of pal-liative care group were slightly higher than those of standard care group (Before exposure: 20 092.3 yuan <i>vs</i>. 19 132.8 yuan, <i>P</i>=0.725; After exposure: 9 719.8 yuan <i>vs</i>. 8 818.8 yuan, <i>P</i>=0.165). Palliative care increased the average monthly total cost by 2 208.8 yuan, but it was not statistically significant (<i>P</i>=0.316).</p><p><strong>Conclusion: </strong>Palliative care can increase the opioid consumption in advanced cancer patients, reduce the rates of hospitalization, ICU and surgery, but has no significant effect on medical expenditure.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"996-1001"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities]. [类风湿关节炎患者血清中lumican蛋白的表达及其与疾病和免疫活动的相关性]。
Q3 Medicine Pub Date : 2025-10-18
Ju Yang, Jing Xu, Juhua Dai, Lianjie Shi
<p><strong>Objective: </strong>To investigate the serum level of lumican (LUM) and its clinical correlation with disease and immune activities in patients with rheumatoid arthritis (RA).</p><p><strong>Methods: </strong>The serum LUM levels in both RA patients and health controls (HCs) were detected by enzyme-linked immunosorbent assay (ELISA). The clinical and laboratory data of the patients were collected. The LUM levels in the patients with different clinical features were analyzed. The correlation between the clinical data, laboratory parameters, and serum LUM levels were also analyzed. Independent samples <i>t</i> test, Spearman correlation were used for statistical analysis. Analysis of variance and Kruskal-Wallis test, the least significant difference (LSD)-<i>t</i> test and Bonferroni correction were used for statistical analysis. The Pearson Chi-square test was used for comparison of the rates between the groups. Statistical significance was set at <i>P</i> < 0.05.</p><p><strong>Results: </strong>The levels of LUM were elevated in the RA patients than in the HCs (<i>P</i> < 0.000 1). Serum LUM levels were correlated with the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), immunoglobulin A (IgA), titers of platelet (PLT) and 28-joint disease activity score (DAS28, all <i>P</i> < 0.05). Next, we compared the serum LUM levels in the RA patients with different characteristics, and no difference was found in serum LUM levels between early-RA and RA, the same to RA with different gender (<i>P</i>>0.05). The levels of serum LUM were elevated in the RF positive patients (<i>P</i> < 0.000 1), and in the RF and anti-CCP positive patients (<i>P</i> < 0.05) than in the RA patients with negative RF whether the anti-CCP was positive. In addition, no differences were found between the RA patients with negative RF whether the anti-CCP was positive (<i>P</i>>0.05). All the levels of serum LUM were elevated in the RA patients with different CRP or ESR than in the HCs (<i>P</i> < 0.05), and the serum LUM levels in the RA patients with elevated ESR and CRP were significantly elevated in those with normal ESR and CRP (<i>P</i> < 0.05). Additionally, the results demonstrated that serum LUM levels were positively associated with RA disease activity, and they were declined in RA sustained remission than those in middle or high disease activity (<i>P</i> < 0.05). Furthermore, no difference was found between the RA patients in remission and HCs (<i>P</i>>0.05). No differences were found in the RA patients with and without complications including interstitial pneumonia disease, Sjögren's syndrome, thyroid gland diseases and osteoporosis (<i>P</i>>0.05). The LUM positivity rates were significantly elevated in the RF positive patients than the RF negative patients in RA (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>LUM, a cyclocitrullinated protein, might be a promising biomarker which could reflect both disease activit
目的:探讨类风湿关节炎(RA)患者血清lumican (LUM)水平及其与疾病及免疫活动的临床相关性。方法:采用酶联免疫吸附试验(ELISA)检测RA患者和健康对照者血清LUM水平。收集患者的临床和实验室资料。分析不同临床特征患者的LUM水平。分析临床资料、实验室参数与血清LUM水平的相关性。采用独立样本t检验、Spearman相关进行统计分析。采用方差分析、Kruskal-Wallis检验、LSD -t检验和Bonferroni校正进行统计学分析。采用Pearson卡方检验比较两组间的发生率。差异有统计学意义,P < 0.05。结果:类风湿关节炎患者中LUM水平明显高于hcc患者(P < 0.0001)。血清LUM水平与红细胞沉降率(ESR)、c反应蛋白(CRP)、类风湿因子(RF)、免疫球蛋白A (IgA)、血小板滴度(PLT)、28关节疾病活动性评分(DAS28)相关,均P < 0.05。接下来,我们比较了不同特征RA患者的血清LUM水平,发现早期RA与RA之间血清LUM水平无差异,不同性别RA之间血清LUM水平无差异(P < 0.05)。RF阳性患者血清LUM水平升高(P < 0.000 1), RF和抗ccp阳性患者血清LUM水平均高于RF阴性RA患者(P < 0.05)。此外,RF阴性的RA患者抗ccp是否阳性,差异无统计学意义(P < 0.05)。不同CRP、ESR组RA患者血清LUM水平均高于hc组(P < 0.05), ESR、CRP升高组RA患者血清LUM水平显著高于ESR、CRP正常组(P < 0.05)。此外,结果显示血清LUM水平与RA疾病活动性呈正相关,并且RA持续缓解时其水平低于中度或高度疾病活动性(P < 0.05)。此外,缓解期RA患者与hcc患者之间无差异(P < 0.05)。合并间质性肺炎、Sjögren综合征、甲状腺疾病、骨质疏松等并发症的RA患者与不合并间质性肺炎、Sjögren综合征、甲状腺疾病、骨质疏松的RA患者无统计学差异(P < 0.05)。RF阳性患者的LUM阳性率明显高于RF阴性患者(P < 0.05)。结论:环腈氨酸化蛋白LUM可能是一种有前景的生物标志物,可以反映RA的疾病活动性和免疫活性。
{"title":"[Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities].","authors":"Ju Yang, Jing Xu, Juhua Dai, Lianjie Shi","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To investigate the serum level of lumican (LUM) and its clinical correlation with disease and immune activities in patients with rheumatoid arthritis (RA).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The serum LUM levels in both RA patients and health controls (HCs) were detected by enzyme-linked immunosorbent assay (ELISA). The clinical and laboratory data of the patients were collected. The LUM levels in the patients with different clinical features were analyzed. The correlation between the clinical data, laboratory parameters, and serum LUM levels were also analyzed. Independent samples &lt;i&gt;t&lt;/i&gt; test, Spearman correlation were used for statistical analysis. Analysis of variance and Kruskal-Wallis test, the least significant difference (LSD)-&lt;i&gt;t&lt;/i&gt; test and Bonferroni correction were used for statistical analysis. The Pearson Chi-square test was used for comparison of the rates between the groups. Statistical significance was set at &lt;i&gt;P&lt;/i&gt; &lt; 0.05.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The levels of LUM were elevated in the RA patients than in the HCs (&lt;i&gt;P&lt;/i&gt; &lt; 0.000 1). Serum LUM levels were correlated with the erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), immunoglobulin A (IgA), titers of platelet (PLT) and 28-joint disease activity score (DAS28, all &lt;i&gt;P&lt;/i&gt; &lt; 0.05). Next, we compared the serum LUM levels in the RA patients with different characteristics, and no difference was found in serum LUM levels between early-RA and RA, the same to RA with different gender (&lt;i&gt;P&lt;/i&gt;&gt;0.05). The levels of serum LUM were elevated in the RF positive patients (&lt;i&gt;P&lt;/i&gt; &lt; 0.000 1), and in the RF and anti-CCP positive patients (&lt;i&gt;P&lt;/i&gt; &lt; 0.05) than in the RA patients with negative RF whether the anti-CCP was positive. In addition, no differences were found between the RA patients with negative RF whether the anti-CCP was positive (&lt;i&gt;P&lt;/i&gt;&gt;0.05). All the levels of serum LUM were elevated in the RA patients with different CRP or ESR than in the HCs (&lt;i&gt;P&lt;/i&gt; &lt; 0.05), and the serum LUM levels in the RA patients with elevated ESR and CRP were significantly elevated in those with normal ESR and CRP (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). Additionally, the results demonstrated that serum LUM levels were positively associated with RA disease activity, and they were declined in RA sustained remission than those in middle or high disease activity (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). Furthermore, no difference was found between the RA patients in remission and HCs (&lt;i&gt;P&lt;/i&gt;&gt;0.05). No differences were found in the RA patients with and without complications including interstitial pneumonia disease, Sjögren's syndrome, thyroid gland diseases and osteoporosis (&lt;i&gt;P&lt;/i&gt;&gt;0.05). The LUM positivity rates were significantly elevated in the RF positive patients than the RF negative patients in RA (&lt;i&gt;P&lt;/i&gt; &lt; 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;LUM, a cyclocitrullinated protein, might be a promising biomarker which could reflect both disease activit","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"911-918"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549364/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Influence of long-term biologic therapy on metabolic biochemical parameters in moderate to severe plaque psoriasis]. [长期生物治疗对中重度斑块型银屑病代谢生化参数的影响]。
Q3 Medicine Pub Date : 2025-10-18
Xiangxian Liu, Yi Lin, Jinzhu Guo
<p><strong>Objective: </strong>To assess the impact of long-term biologic therapy on metabolic biochemical parameters in moderate to severe plaque psoriasis patients.</p><p><strong>Methods: </strong>The study included patients over 18 years old who had been treated by biological agents for at least 24 weeks for moderate to severe plaque psoriasis from Novermber 2015 to January 2024. According to the biological agents the patients used, they were divided into three groups: interleukin-17 (IL-17) inhibitor group, IL-23 and IL-12/23 inhibitor group and tumor necrosis factor-α (TNF-α) inhibitor group. The metabolic biochemical parameters of each group were evaluated and compared before and after the administration of the biologic therapies.</p><p><strong>Results: </strong>A total of 174 patients with moderate to severe plaque psoriasis were included in the long-term treatment with biologics, including 127 males (73.00%), 47 females (27.00%), with a median age of 38.00 (31.50, 49.00) years and a median duration of psoriasis of 12.00 (10.00, 20.00) years. The median duration of biologic treatment was 61.00 (49.00, 96.25) weeks, ranging from 26 to 301 weeks. There were 101 patients in the IL-17 inhibitor group, 38 patients in the IL-23 and IL-12/23 inhibitor group, and 35 patients in the TNF-α inhibitor group. After long-term treatment with IL-17 inhibitors, no statistically significant changes were observed in body weight, body mass index (BMI), alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting glucose (GLU), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) compared with baseline measurements (<i>P</i>>0.05). However, low-density lipoprotein cholesterol (LDL-C) levels were significantly reduced [(2.90±0.75) mmol/L <i>vs</i>. (3.05±0.79) mmol/L, <i>t</i>=-2.100, <i>P</i>=0.038], while uric acid (UA) levels showed a significant increase [(401.13±99.13) μmol/L <i>vs</i>. (364.94±91.11) μmol/L, <i>t</i>=5.215, <i>P</i> < 0.001]. The group with normal UA levels before treatment showed a significant increase after long-term application of biological agents compared with before treatment [(370.69± 89.59) μmol/L <i>vs</i>. (324.66±64.50) μmol/L, <i>t</i>=5.856, <i>P</i> < 0.001]. Following long-term application of IL-23 and IL-12/23 inhibitors, no statistically significant differences were observed in body weight, BMI, ALT, AST, GLU, TC, TG, HDL-C and UA levels when compared with baseline measurements (<i>P</i>> 0.05). However, LDL-C levels exhibited a significant reduction from baseline [(2.85±0.74) mmol/L <i>vs</i>. (3.12±0.68) mmol/L, <i>t</i>=-2.082, <i>P</i>=0.045]. After long-term treatment with TNF-α inhibitor, there were no significant differences in body weight, BMI, ALT, AST, GLU, TC, TG, HDL-C, LDL-C and UA compared with baseline measurements (<i>P</i>>0.05).</p><p><strong>Conclusion: </strong>Long-term application of IL-17 inhibitors in moderate to severe plaque psoriasis patients
目的:探讨长期生物治疗对中重度斑块型银屑病患者代谢生化指标的影响。方法:研究纳入了2015年11月至2024年1月期间接受生物制剂治疗至少24周的18岁以上中重度斑块型银屑病患者。根据患者使用的生物制剂分为3组:白细胞介素-17 (IL-17)抑制剂组、IL-23和IL-12/23抑制剂组和肿瘤坏死因子-α (TNF-α)抑制剂组。对各组患者给予生物治疗前后的代谢生化指标进行评价和比较。结果:共纳入174例中重度斑块型银屑病患者,其中男性127例(73.00%),女性47例(27.00%),中位年龄38.00(31.50,49.00)岁,中位银屑病病程12.00(10.00,20.00)年。生物治疗的中位持续时间为61.00(49.00,96.25)周,范围为26 ~ 301周。IL-17抑制剂组101例,IL-23和IL-12/23抑制剂组38例,TNF-α抑制剂组35例。长期使用IL-17抑制剂治疗后,体重、体重指数(BMI)、丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、空腹血糖(GLU)、总胆固醇(TC)、甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-C)与基线值相比无统计学意义变化(P < 0.05)。低密度脂蛋白胆固醇(LDL-C)水平显著降低[(2.90±0.75)mmol/L vs(3.05±0.79)mmol/L, t=-2.100, P=0.038],尿酸(UA)水平显著升高[(401.13±99.13)μmol/L vs(364.94±91.11)μmol/L, t=5.215, P < 0.001]。治疗前正常组长期应用生物制剂后UA水平较治疗前显著升高[(370.69±89.59)μmol/L vs(324.66±64.50)μmol/L, t=5.856, P < 0.001]。长期应用IL-23和IL-12/23抑制剂后,体重、BMI、ALT、AST、GLU、TC、TG、HDL-C、UA水平与基线比较,差异均无统计学意义(P < 0.05)。然而,LDL-C水平较基线有显著降低[(2.85±0.74)mmol/L vs(3.12±0.68)mmol/L, t=-2.082, P=0.045]。经TNF-α抑制剂长期治疗后,体重、BMI、ALT、AST、GLU、TC、TG、HDL-C、LDL-C、UA与基线比较无显著差异(P < 0.05)。结论:中重度斑块型银屑病患者长期应用IL-17抑制剂可导致尿酸水平升高,尤其是治疗前尿酸水平正常的患者。长期使用IL-17抑制剂、IL-23抑制剂或IL-12/23抑制剂可能降低LDL-C水平。
{"title":"[Influence of long-term biologic therapy on metabolic biochemical parameters in moderate to severe plaque psoriasis].","authors":"Xiangxian Liu, Yi Lin, Jinzhu Guo","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To assess the impact of long-term biologic therapy on metabolic biochemical parameters in moderate to severe plaque psoriasis patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The study included patients over 18 years old who had been treated by biological agents for at least 24 weeks for moderate to severe plaque psoriasis from Novermber 2015 to January 2024. According to the biological agents the patients used, they were divided into three groups: interleukin-17 (IL-17) inhibitor group, IL-23 and IL-12/23 inhibitor group and tumor necrosis factor-α (TNF-α) inhibitor group. The metabolic biochemical parameters of each group were evaluated and compared before and after the administration of the biologic therapies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 174 patients with moderate to severe plaque psoriasis were included in the long-term treatment with biologics, including 127 males (73.00%), 47 females (27.00%), with a median age of 38.00 (31.50, 49.00) years and a median duration of psoriasis of 12.00 (10.00, 20.00) years. The median duration of biologic treatment was 61.00 (49.00, 96.25) weeks, ranging from 26 to 301 weeks. There were 101 patients in the IL-17 inhibitor group, 38 patients in the IL-23 and IL-12/23 inhibitor group, and 35 patients in the TNF-α inhibitor group. After long-term treatment with IL-17 inhibitors, no statistically significant changes were observed in body weight, body mass index (BMI), alanine aminotransferase (ALT), aspartate aminotransferase (AST), fasting glucose (GLU), total cholesterol (TC), triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) compared with baseline measurements (&lt;i&gt;P&lt;/i&gt;&gt;0.05). However, low-density lipoprotein cholesterol (LDL-C) levels were significantly reduced [(2.90±0.75) mmol/L &lt;i&gt;vs&lt;/i&gt;. (3.05±0.79) mmol/L, &lt;i&gt;t&lt;/i&gt;=-2.100, &lt;i&gt;P&lt;/i&gt;=0.038], while uric acid (UA) levels showed a significant increase [(401.13±99.13) μmol/L &lt;i&gt;vs&lt;/i&gt;. (364.94±91.11) μmol/L, &lt;i&gt;t&lt;/i&gt;=5.215, &lt;i&gt;P&lt;/i&gt; &lt; 0.001]. The group with normal UA levels before treatment showed a significant increase after long-term application of biological agents compared with before treatment [(370.69± 89.59) μmol/L &lt;i&gt;vs&lt;/i&gt;. (324.66±64.50) μmol/L, &lt;i&gt;t&lt;/i&gt;=5.856, &lt;i&gt;P&lt;/i&gt; &lt; 0.001]. Following long-term application of IL-23 and IL-12/23 inhibitors, no statistically significant differences were observed in body weight, BMI, ALT, AST, GLU, TC, TG, HDL-C and UA levels when compared with baseline measurements (&lt;i&gt;P&lt;/i&gt;&gt; 0.05). However, LDL-C levels exhibited a significant reduction from baseline [(2.85±0.74) mmol/L &lt;i&gt;vs&lt;/i&gt;. (3.12±0.68) mmol/L, &lt;i&gt;t&lt;/i&gt;=-2.082, &lt;i&gt;P&lt;/i&gt;=0.045]. After long-term treatment with TNF-α inhibitor, there were no significant differences in body weight, BMI, ALT, AST, GLU, TC, TG, HDL-C, LDL-C and UA compared with baseline measurements (&lt;i&gt;P&lt;/i&gt;&gt;0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Long-term application of IL-17 inhibitors in moderate to severe plaque psoriasis patients ","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"934-940"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neuroendocrine carcinoma with significantly vacuolar nucleus at the esophagogastric junction: A case report]. 食管胃交界处神经内分泌癌伴明显空泡核1例。
Q3 Medicine Pub Date : 2025-10-18
Weihua Hou, Shujie Song, Zhongyue Shi, Lu Liu, Mulan Jin

Neoplasms characterized by the expression of markers of neuroendocrine differentiation in neoplastic cells are defined as neuroendocrine neoplasms. A case of neuroendocrine carcinomas (NECs) with a small amount of papillary adenocarcinoma and significantly vacuolar nucleus at the esophagogastric junction was reported in this article. A 77-year-old male had dysphagia for one week. Endoscopy revealed early-stage esophagogastric junction carcinoma, and biopsy was diagnosed as poorly differentiated carcinoma. Endoscopic submucosal dissection was performed. Histologically, the papillary adenocarcinoma progresses from typically branching papillary structures (well-differentiated) to hyperplasia of the lining epithelium of the papilla to form a cribriform structure (moderately differentiated), to solid area lacking papillary structures (poorly differentiated). There was a continuous process, and during this process, the vacuoles in the nuclei of tumor cells showed progressive changes from mild to obvious and finally to significant vacuoles. The tumor was mainly composed of solid areas (about 95%), with single cell, large cell, round or oval to irregular nuclei, and significantly vacuolar nuclei, nuclei with larger vacuoles appeared in a loop, a few thin weakly basophilic or weakly eosinophilic fine particles could be seen in the vacuoles, and the vacuoles had rough edges. The nucleus chromatin at the outer edge of the vacuoles was fine particles, and mitosis was common (20-30/mm2), atypical mitosis could be seen, and nucleoli could be seen easily, the cytoplasm was weakly eosinophilic, and the boundaries of cells were unclear. The cells were arranged in a nested, trabecular, or diffuse sheet shape, with some arranged in a glandular tube shape. Tumor thrombus was found in the vein of submucosa; the interstitial tissue rich in capillaries within the tumor was accompanied by a large number of neutrophil infiltration. Immunohistochemical staining showed that the solid area of the tumor was positive for synaptophysin (Syn) and chromogranin A (CgA), while papillary adenocarcinoma was negative. Mucin 5AC (MUC5AC) was diffusely positive in papillary adenocarcinoma, while the proportion of positive cells in the solid area of the tumor was about 10% to 15%. In a word, this case showed the extreme situation of the vacuolar nuclear characteristics of NECs, extremely rare, in a sense, this case expanded the boundary of the morphological spectrum of NECs. Understanding the extreme vacuolar features of this nucleus is helpful to make a correct pathological diagnosis.

以肿瘤细胞表达神经内分泌分化标志物为特征的肿瘤被定义为神经内分泌肿瘤。本文报告1例神经内分泌癌(NECs)伴少量乳头状腺癌,并在食管胃交界处有明显的空泡核。77岁男性,有吞咽困难1周。内镜检查发现早期食管胃交界癌,活检诊断为低分化癌。内镜下粘膜夹层。组织学上,乳头状腺癌从典型的分枝状乳头状结构(高分化)发展到乳头内膜上皮增生形成筛状结构(中度分化),再到缺乏乳头状结构的实区(低分化)。这是一个连续的过程,在这个过程中,肿瘤细胞核内的液泡由轻微到明显,最后到显著的液泡变化。肿瘤以实区为主(约95%),有单细胞、大细胞、圆形或卵圆形至不规则核,可见明显的空泡核,较大的空泡核呈环状,空泡内可见少量薄的弱嗜碱性或弱嗜酸性细颗粒,空泡边缘粗糙。液泡外缘核染色质呈细颗粒状,有丝分裂常见(20 ~ 30/mm2),可见非典型有丝分裂,易见核仁,细胞质嗜酸性弱,细胞边界不清。细胞呈巢状、小梁状或弥散片状排列,部分细胞呈腺管状排列。粘膜下静脉可见肿瘤血栓;肿瘤内毛细血管丰富的间质组织伴大量中性粒细胞浸润。免疫组化染色显示肿瘤实区突触素(Syn)和嗜铬粒蛋白A (CgA)阳性,乳头状腺癌阴性。Mucin 5AC (MUC5AC)在乳头状腺癌中呈弥漫性阳性,肿瘤实区阳性细胞比例约为10% ~ 15%。总之,本病例显示了NECs液泡核特征的极端情况,极为罕见,从某种意义上说,本病例拓展了NECs形态学谱的边界。了解该核的极端空泡特征有助于做出正确的病理诊断。
{"title":"[Neuroendocrine carcinoma with significantly vacuolar nucleus at the esophagogastric junction: A case report].","authors":"Weihua Hou, Shujie Song, Zhongyue Shi, Lu Liu, Mulan Jin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neoplasms characterized by the expression of markers of neuroendocrine differentiation in neoplastic cells are defined as neuroendocrine neoplasms. A case of neuroendocrine carcinomas (NECs) with a small amount of papillary adenocarcinoma and significantly vacuolar nucleus at the esophagogastric junction was reported in this article. A 77-year-old male had dysphagia for one week. Endoscopy revealed early-stage esophagogastric junction carcinoma, and biopsy was diagnosed as poorly differentiated carcinoma. Endoscopic submucosal dissection was performed. Histologically, the papillary adenocarcinoma progresses from typically branching papillary structures (well-differentiated) to hyperplasia of the lining epithelium of the papilla to form a cribriform structure (moderately differentiated), to solid area lacking papillary structures (poorly differentiated). There was a continuous process, and during this process, the vacuoles in the nuclei of tumor cells showed progressive changes from mild to obvious and finally to significant vacuoles. The tumor was mainly composed of solid areas (about 95%), with single cell, large cell, round or oval to irregular nuclei, and significantly vacuolar nuclei, nuclei with larger vacuoles appeared in a loop, a few thin weakly basophilic or weakly eosinophilic fine particles could be seen in the vacuoles, and the vacuoles had rough edges. The nucleus chromatin at the outer edge of the vacuoles was fine particles, and mitosis was common (20-30/mm<sup>2</sup>), atypical mitosis could be seen, and nucleoli could be seen easily, the cytoplasm was weakly eosinophilic, and the boundaries of cells were unclear. The cells were arranged in a nested, trabecular, or diffuse sheet shape, with some arranged in a glandular tube shape. Tumor thrombus was found in the vein of submucosa; the interstitial tissue rich in capillaries within the tumor was accompanied by a large number of neutrophil infiltration. Immunohistochemical staining showed that the solid area of the tumor was positive for synaptophysin (Syn) and chromogranin A (CgA), while papillary adenocarcinoma was negative. Mucin 5AC (MUC5AC) was diffusely positive in papillary adenocarcinoma, while the proportion of positive cells in the solid area of the tumor was about 10% to 15%. In a word, this case showed the extreme situation of the vacuolar nuclear characteristics of NECs, extremely rare, in a sense, this case expanded the boundary of the morphological spectrum of NECs. Understanding the extreme vacuolar features of this nucleus is helpful to make a correct pathological diagnosis.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"1005-1009"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes]. 泛素特异性蛋白酶35在类风湿关节炎-成纤维细胞样滑膜细胞铁下垂中的作用和机制。
Q3 Medicine Pub Date : 2025-10-18
Lianghua Feng, Lirong Hong, Yujia Chen, Xueming Cai

Objective: To elucidate the role and underlying mechanism of ubiquitin-specific protease 35 (USP35) in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes (RA-FLS), thereby enhancing our comprehension of the pathogenesis of RA and identifying potential therapeutic targets for its treatment.

Methods: (1) RA-FLS were cultured in vitro and transduced with lentiviral vectors to establish stable cell lines: A USP35-knockdown line (short hairpin ribonucleic acid of USP35, shUSP35) and its control (negtive control of short hairpin ribonucleic acid, shNC), as well as a overexpression of USP35 line (USP35 OE) and its control (Vector). To investigate the role of USP35 in ferroptosis regulation, a ferroptosis model was induced in RA-FLS by treatment with 1 μmol/L Erastin. The cells were divided into six groups: shNC, shNC + Erastin, shUSP35 + Erastin, Vector, Vector + Erastin, and USP35 OE + Erastin. (2) Cell viability was detected using the cell counting kit-8 (CCK-8). (3) Reactive oxygen species (ROS), malondialdehyde (MDA), glutathione/glutathione disulfide (GSH/GSSG) ratios, and Ferrous ion (Fe2+) levels were measured using specific assay kits to evaluate oxidative stress, lipid peroxidation, and glutathione redox status in the cells. (4) Protein expression levels of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) were detected using Western blotting to investigate their potential involvement in USP35-mediated ferroptosis regulation.

Results: (1) Compared with the shNC +Erastin group, the cell viability of the shUSP35+Erastin group was significantly decreased (P < 0.001), while it was notably increased in the USP35 OE+Erastin group compared with the Vector+Erastin group (P < 0.001). These findings indicated that USP35 could alleviate the inhibitory effect of Erastin on RA-FLS cell viability. (2) In comparison to the shNC+Erastin group, the levels of ROS (P < 0.001), MDA (P < 0.05), and Fe2+ (P < 0.001) were significantly elevated, and the GSH/GSSG ratio was increased (P < 0.05) in the shUSP35+Erastin group. Conversely, the levels of ROS (P < 0.001), MDA (P < 0.05), and Fe2+ (P < 0.05) were significantly decreased, and the GSH/GSSG ratio was decreased (P < 0.05) in the USP35 OE+Erastin group compared with the Vector+Erastin group. These results suggested that USP35 could inhibit Erastin-induced oxidative stress and lipid peroxidation in RA-FLS. (3) In Erastin-induced RA-FLS, the expression of USP35 was positively correlated with the protein levels of SLC7A11 and GPX4, indicating a potential mechanism by which USP35 regulated ferroptosis in these cells.

Conclusion: USP35 inhibits ferroptosis in RA-FLS, potentially through the increased expression of SLC7A11 and GPX4.

目的:阐明泛素特异性蛋白酶35 (USP35)在类风湿关节炎-成纤维细胞样滑膜细胞(RA- fls)铁上睑滑移中的作用及其机制,从而提高我们对RA发病机制的认识,并寻找潜在的治疗靶点。方法:(1)体外培养RA-FLS,用慢病毒载体转导,建立稳定的细胞系:USP35敲低细胞系(USP35短发夹核糖核酸,shUSP35)及其对照(短发夹核糖核酸阴性对照,shNC), USP35过表达细胞系(USP35 OE)及其对照(载体)。为了研究USP35在铁下垂调控中的作用,采用1 μmol/L Erastin诱导RA-FLS铁下垂模型。将细胞分为shNC、shNC + Erastin、shUSP35 + Erastin、Vector、Vector + Erastin、USP35 OE + Erastin 6组。(2)采用细胞计数试剂盒-8 (CCK-8)检测细胞活力。(3)采用特异性试剂盒测定细胞中的活性氧(ROS)、丙二醛(MDA)、谷胱甘肽/谷胱甘肽二硫(GSH/GSSG)比值和亚铁离子(Fe2+)水平,以评估细胞中的氧化应激、脂质过氧化和谷胱甘肽氧化还原状态。(4)采用Western blotting检测溶质载体家族7成员11 (SLC7A11)和谷胱甘肽过氧化物酶4 (GPX4)的蛋白表达水平,探讨其在usp35介导的铁凋亡调控中的潜在作用。结果:(1)与shNC +Erastin组相比,shUSP35+Erastin组细胞活力显著降低(P < 0.001),而与Vector+Erastin组相比,USP35 OE+Erastin组细胞活力显著升高(P < 0.001)。这些结果表明USP35可以减轻Erastin对RA-FLS细胞活力的抑制作用。(2)与shNC+Erastin组比较,shUSP35+Erastin组的ROS (P < 0.001)、MDA (P < 0.05)、Fe2+ (P < 0.001)水平显著升高,GSH/GSSG比值显著升高(P < 0.05)。相反,与Vector+Erastin组相比,USP35 OE+Erastin组的ROS (P < 0.001)、MDA (P < 0.05)、Fe2+ (P < 0.05)水平显著降低,GSH/GSSG比值显著降低(P < 0.05)。提示USP35可抑制erastin诱导的RA-FLS氧化应激和脂质过氧化。(3)在erastin诱导的RA-FLS中,USP35的表达与SLC7A11和GPX4蛋白水平呈正相关,提示USP35调控这些细胞铁下垂的潜在机制。结论:USP35可能通过增加SLC7A11和GPX4的表达来抑制RA-FLS中的铁下垂。
{"title":"[Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes].","authors":"Lianghua Feng, Lirong Hong, Yujia Chen, Xueming Cai","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To elucidate the role and underlying mechanism of ubiquitin-specific protease 35 (USP35) in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes (RA-FLS), thereby enhancing our comprehension of the pathogenesis of RA and identifying potential therapeutic targets for its treatment.</p><p><strong>Methods: </strong>(1) RA-FLS were cultured <i>in vitro</i> and transduced with lentiviral vectors to establish stable cell lines: A USP35-knockdown line (short hairpin ribonucleic acid of USP35, shUSP35) and its control (negtive control of short hairpin ribonucleic acid, shNC), as well as a overexpression of USP35 line (USP35 OE) and its control (Vector). To investigate the role of USP35 in ferroptosis regulation, a ferroptosis model was induced in RA-FLS by treatment with 1 μmol/L Erastin. The cells were divided into six groups: shNC, shNC + Erastin, shUSP35 + Erastin, Vector, Vector + Erastin, and USP35 OE + Erastin. (2) Cell viability was detected using the cell counting kit-8 (CCK-8). (3) Reactive oxygen species (ROS), malondialdehyde (MDA), glutathione/glutathione disulfide (GSH/GSSG) ratios, and Ferrous ion (Fe<sup>2+</sup>) levels were measured using specific assay kits to evaluate oxidative stress, lipid peroxidation, and glutathione redox status in the cells. (4) Protein expression levels of solute carrier family 7 member 11 (SLC7A11) and glutathione peroxidase 4 (GPX4) were detected using Western blotting to investigate their potential involvement in USP35-mediated ferroptosis regulation.</p><p><strong>Results: </strong>(1) Compared with the shNC +Erastin group, the cell viability of the shUSP35+Erastin group was significantly decreased (<i>P</i> < 0.001), while it was notably increased in the USP35 OE+Erastin group compared with the Vector+Erastin group (<i>P</i> < 0.001). These findings indicated that USP35 could alleviate the inhibitory effect of Erastin on RA-FLS cell viability. (2) In comparison to the shNC+Erastin group, the levels of ROS (<i>P</i> < 0.001), MDA (<i>P</i> < 0.05), and Fe<sup>2+</sup> (<i>P</i> < 0.001) were significantly elevated, and the GSH/GSSG ratio was increased (<i>P</i> < 0.05) in the shUSP35+Erastin group. Conversely, the levels of ROS (<i>P</i> < 0.001), MDA (<i>P</i> < 0.05), and Fe<sup>2+</sup> (<i>P</i> < 0.05) were significantly decreased, and the GSH/GSSG ratio was decreased (<i>P</i> < 0.05) in the USP35 OE+Erastin group compared with the Vector+Erastin group. These results suggested that USP35 could inhibit Erastin-induced oxidative stress and lipid peroxidation in RA-FLS. (3) In Erastin-induced RA-FLS, the expression of USP35 was positively correlated with the protein levels of SLC7A11 and GPX4, indicating a potential mechanism by which USP35 regulated ferroptosis in these cells.</p><p><strong>Conclusion: </strong>USP35 inhibits ferroptosis in RA-FLS, potentially through the increased expression of SLC7A11 and GPX4.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"919-925"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma]. [前列腺导管腺癌腺外浸润的临床特点及影响因素]。
Q3 Medicine Pub Date : 2025-10-18
Xiaoyong Yang, Fan Zhang, Lulin Ma, Cheng Liu

Objective: To explore the differences in perioperative clinical and pathological characteristics of patients with different pathological types of prostate cancer undergoing radical prostatectomy, and to analyze the influencing factors that may affect the extraglandular invasion of ductal adenocarcinoma of the prostate.

Methods: Retrospective collection was made of the radical prostatectomy patients who were admitted to Peking University Third Hospital from December 2011 to April 2021. The patients were screened based on inclusion criteria to obtain basic clinical features and postoperative pathological results. According to the pathological results, the patients were divided into ductal adenocarcinoma group (mixed with ductal adenocarcinoma) and acinar adenocarcinoma group, and a 1 ∶1 propensity score matching was performed to compare the differences in clinical characteristics between the two groups. Univariate and multivariate analyses of the factors related to extraglandular invasion were performed in the matched ductal adenocarcinoma groups.

Results: A total of 764 patients with prostate cancer were enrolled in this study, of which 62 patients were confirmed to have ductal adenocarcinoma components by postoperative pathology. There was a statistically significant difference in the proportion of the patients with a history of diabetes in baseline characteristics between the two groups before propensity score matching (29.5% vs. 17.7%, P=0.027). A total of 61 patients with simple acinar adenocarcinoma were successfully matched with the patients with ductal adenocarcinoma, and there was no statistically significant difference in baseline characteristics between the two groups after matching (P>0.05). The comparison of perioperative clinical and pathological features showed that International Society of Urology Pathology (ISUP) grade (P=0.003), pT stage (P=0.004), extraglandular invasion rate (P=0.018) and vascular thrombus rate (P=0.019) in ductal adenocarcinoma group were significantly higher than those in simple acinous adenocarcinoma group. Univariate analysis of the influence factors of extraglandular invasion showed that prostate-specific antigen (PSA) level, prostate volume, ISUP grade, seminal vesicle invasion and perineural invasion might be the influencing factors of extraglandular invasion (P < 0.10). Binary Logistic regression analysis showed that perineural invasion was an independent factor of extraglandular invasion (OR=11.78, 95%CI: 1.97-70.56, P=0.007).

Conclusion: Prostatic ductal adenocarcinoma has a worse prognosis than simple acinar adenocarcinoma. Perineural invasion is the influencing factor of extraglandular invasion of ductal adenocarcinoma.

目的:探讨不同病理类型前列腺癌根治术患者围手术期临床及病理特征的差异,分析可能影响前列腺导管腺癌腺外浸润的影响因素。方法:回顾性收集2011年12月至2021年4月北京大学第三医院根治性前列腺切除术患者。根据入选标准对患者进行筛选,获得基本临床特征和术后病理结果。根据病理结果将患者分为导管腺癌组(合并导管腺癌)和腺泡腺癌组,采用1∶1倾向评分匹配比较两组患者临床特征的差异。在匹配的导管腺癌组中对腺外浸润相关因素进行单因素和多因素分析。结果:本研究共纳入764例前列腺癌患者,其中62例患者术后病理证实有导管腺癌成分。两组患者在倾向评分匹配前有糖尿病史的患者在基线特征中的比例差异有统计学意义(29.5% vs. 17.7%, P=0.027)。61例单纯性腺泡癌患者与导管腺癌患者成功配对,配对后两组基线特征比较,差异无统计学意义(P < 0.05)。围手术期临床及病理特征比较显示,导管腺癌组的ISUP分级(P=0.003)、pT分期(P=0.004)、腺外浸润率(P=0.018)及血管血栓率(P=0.019)均显著高于单纯腺酸腺癌组。单因素分析显示,前列腺特异抗原(PSA)水平、前列腺体积、ISUP分级、精囊浸润和神经周围浸润可能是前列腺外浸润的影响因素(P < 0.10)。二元Logistic回归分析显示,神经周围浸润是腺外浸润的独立因素(OR=11.78, 95%CI: 1.97 ~ 70.56, P=0.007)。结论:前列腺导管腺癌预后较单纯腺泡腺癌差。神经周围浸润是导管腺癌腺外浸润的影响因素。
{"title":"[Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma].","authors":"Xiaoyong Yang, Fan Zhang, Lulin Ma, Cheng Liu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To explore the differences in perioperative clinical and pathological characteristics of patients with different pathological types of prostate cancer undergoing radical prostatectomy, and to analyze the influencing factors that may affect the extraglandular invasion of ductal adenocarcinoma of the prostate.</p><p><strong>Methods: </strong>Retrospective collection was made of the radical prostatectomy patients who were admitted to Peking University Third Hospital from December 2011 to April 2021. The patients were screened based on inclusion criteria to obtain basic clinical features and postoperative pathological results. According to the pathological results, the patients were divided into ductal adenocarcinoma group (mixed with ductal adenocarcinoma) and acinar adenocarcinoma group, and a 1 ∶1 propensity score matching was performed to compare the differences in clinical characteristics between the two groups. Univariate and multivariate analyses of the factors related to extraglandular invasion were performed in the matched ductal adenocarcinoma groups.</p><p><strong>Results: </strong>A total of 764 patients with prostate cancer were enrolled in this study, of which 62 patients were confirmed to have ductal adenocarcinoma components by postoperative pathology. There was a statistically significant difference in the proportion of the patients with a history of diabetes in baseline characteristics between the two groups before propensity score matching (29.5% <i>vs.</i> 17.7%, <i>P</i>=0.027). A total of 61 patients with simple acinar adenocarcinoma were successfully matched with the patients with ductal adenocarcinoma, and there was no statistically significant difference in baseline characteristics between the two groups after matching (<i>P</i>>0.05). The comparison of perioperative clinical and pathological features showed that International Society of Urology Pathology (ISUP) grade (<i>P</i>=0.003), pT stage (<i>P</i>=0.004), extraglandular invasion rate (<i>P</i>=0.018) and vascular thrombus rate (<i>P</i>=0.019) in ductal adenocarcinoma group were significantly higher than those in simple acinous adenocarcinoma group. Univariate analysis of the influence factors of extraglandular invasion showed that prostate-specific antigen (PSA) level, prostate volume, ISUP grade, seminal vesicle invasion and perineural invasion might be the influencing factors of extraglandular invasion (<i>P</i> < 0.10). Binary Logistic regression analysis showed that perineural invasion was an independent factor of extraglandular invasion (<i>OR</i>=11.78, 95%<i>CI</i>: 1.97-70.56, <i>P</i>=0.007).</p><p><strong>Conclusion: </strong>Prostatic ductal adenocarcinoma has a worse prognosis than simple acinar adenocarcinoma. Perineural invasion is the influencing factor of extraglandular invasion of ductal adenocarcinoma.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"956-960"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
北京大学学报(医学版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1